Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection

Area of Science:

• Immunology
• Transplantation Biology
• Molecular Medicine

Background:

• Myeloid differentiation protein 88 (MyD88) is a key mediator in kidney allograft rejection.
• The exact role of MyD88 signaling in host immune responses driving rejection is not fully understood.

Purpose of the Study:

• To elucidate the precise function of MyD88 signaling in T cells during kidney allograft rejection.
• To investigate the impact of MyD88 deficiency on immune cell infiltration and graft function.

Main Methods:

• Utilized a stringent mouse model of allogeneic kidney transplantation.
• Analyzed graft infiltrating effector cells (e.g., CD11b(-)Gr-1(+) cells, CD8 T cells) and renal graft function.
• Performed ex vivo mixed lymphocyte cultures to assess T cell recall responses and chemokine receptor expression.

Main Results:

• MyD88 deficiency in recipients led to spontaneous reduction of effector cells and improved graft function, resulting in long-term acceptance.
• T cells from MyD88(-/-) recipients showed impaired recall responses and reduced expression of CCR4 and CXCR3.
• Exogenous IL-6 partially restored T cell proliferation in MyD88(-/-) recipients.

Conclusions:

• Intrinsic MyD88 signaling in T cells is essential for mounting a robust rejection response.
• Lack of MyD88 in T cells impairs their accumulation in allografts, leading to spontaneous resolution of acute rejection and graft protection.